Craig Hofmeister, MD

Craig C. Hofmeister, MD, MPH, is professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine and the Winship Cancer Institute. Board certified in internal medicine and hematology, Dr. Hofmeister’s practice focuses on plasma cell cancers, including plasmacytomas, multiple myeloma, AL amyloidosis, smoldering myeloma, and monoclonal gammopathies of renal significance. He started practicing with Emory Healthcare in 2018.

Dr. Hofmeister’s research interests include relapsed myeloma, improving the efficacy of stem cell transplantation, and the development of monoclonal antibodies. He has extensive experience in developing and leading clinical trials in the upfront and relapsed myeloma settings. Dr. Hofmeister was a finalist for the first Myeloma Crowd Research Initiative grants competition for his research in CAR T cell research to target the monoclonal antibody CS 1. He also serves on the steering committee of the Multiple Myeloma Research Consortium (MMRC).

Dr. Hofmeister completed his residency and fellowships in hematology/oncology and transplant at the Loyola University Medical Center in Chicago, IL. He earned his medical degree at The Ohio State University College of Medicine in Columbus, OH.